Skip to content
drillr.ai
Sign up

CNTN

Tharimmune, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.28
+1.11%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue1.5M————
Cost of Revenue—————
Gross Profit1.5M————
Operating Expenses
R&D Expense2.2M3.1M6.4M3.6M2.3M
SG&A Expense53.1M17.0M6.0M5.9M4.6M
General & Admin Expense53.1M17.0M6.0M5.9M4.6M
Selling & Marketing Expense—————
Other Expenses—————
Total Operating Expenses55.3M20.1M12.4M9.5M6.9M
Cost and Expenses55.3M20.1M12.4M9.5M6.9M
Operating Income (EBIT)(53.8M)(20.1M)(12.4M)(9.5M)(6.9M)
Non-Operating
Interest Income655.8K41.4K249.9K152.6K—
Interest Expense13.7K28.3K13.7K16.5K1.6M
Net Interest Income642.1K13.1K236.2K136.1K(1.6M)
Other Non-Op Income/Expense(60.1M)(22.0M)236.2K136.1K(1.6M)
Non-Operating Income (excl Interest)33.9M22.0M(222.5K)(152.6K)—
EBT (Pre-Tax Income)(113.9M)(42.1M)(12.2M)(9.3M)(8.5M)
Income Tax Expense(17.1M)(6.2M)———
Bottom Line
Net Income(98.1M)(35.9M)(12.2M)(9.3M)(8.5M)
Earnings from Cont. Ops(96.8M)(35.9M)(12.2M)(9.3M)(8.5M)
Earnings from Discont. Ops(1.3M)————
Bottom Line Net Income(98.1M)(35.9M)(12.2M)(9.3M)(8.5M)
Per Share
Basic EPS($1.57)($1.12)($9.41)($107.08)($280.77)
Diluted EPS($1.57)($1.12)($9.41)($107.08)($280.77)
Revenue Per Share$0.01$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding216.9M32.0M1.3M8702930178
Diluted Shares Outstanding216.9M32.0M1.3M8702930178
Profitability Metrics
EBITDA(87.7M)(42.1M)(12.2M)(9.1M)(6.7M)
D&A24.8K24.8K—152.6K228.5K
EBIT(87.7M)(42.1M)(12.2M)(9.3M)(6.9M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026